Skip to content

IN THIS CLINICAL TRIAL RANDOM PEOPLE WITH DADRU KUSHTA WILL BE SELECTED TO TEST VISHA TAILA LEPA APPLICATION FOR TREATMENT

A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF VISHATAILA LEPA IN DADRU KUSTHA W.S.R TO TINEA CORPORIS - DADRU

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091464
Enrollment
30
Registered
2025-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

SDM AYURVEDA COLLEGE HOSPITAL AND RESEARCH CENTRE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient full filling the following criteria of Dadru kustha presence of Udgata mandala with or without other features 1 Central Clearing and peripheral spreading 2 Kandu 3 Raaga 4 Pidaka 5 Daha 6 Rookshata 7 Udgata mandala 8 KOH positive skin scrapings obtained from most seriously affected lesion

Exclusion criteria

Exclusion criteria: 1 Subjects having any uncontrolled systemic illness which can interfere with the course of disease and treatment 2 Other overlapping dermatological diseases will be excluded 3 Subjects under Anti-Fungal drugs will be excluded

Design outcomes

Primary

MeasureTime frame
A Number of Mandala B Size of Mandala C Raaga D Number of PidakaTimepoint: AT 0,14,28 DAY

Secondary

MeasureTime frame
A Kandu B Daha C RookshataTimepoint: 14 and 28 days

Countries

India

Contacts

Public ContactDR VEERAKUMARA K

SDM AYURVEDA COLLEGE, HOSPITAL AND RESEARCH CENTRE

khadiravana@gmail.com9743490753

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026